Quest Diagnostics (DGX) Statistics

Quest Diagnostics Inc (DGX) is a leading provider of diagnostic testing, information, and services. As of the latest statistics, the stock has shown a steady growth trajectory. With a market capitalization of over $15 billion, Quest Diagnostics Inc is considered a stable investment option. The valuation metrics of DGX stock also indicate its promising potential. The price-to-earnings ratio is favorable, suggesting that the stock is undervalued. Additionally, the price-to-sales ratio is also favorable, indicating that investors are willing to pay a premium for Quest Diagnostics Inc shares. These valuation metrics further support the attractiveness of DGX stock as an investment opportunity.

When it comes to fundamentals, Quest Diagnostics Inc demonstrates its strength. The company has a solid revenue per share, which is an important indicator of its financial health. This metric shows how much revenue the company generates for each outstanding share of its stock. In the case of Quest Diagnostics Inc, the revenue per share is robust, reflecting its ability to generate sufficient income. Furthermore, the enterprise to EBITDA ratio, which measures the company's profitability, is favorable. This suggests that Quest Diagnostics Inc is able to generate substantial earnings before taxes, interest, depreciation, and amortization. These fundamentals position DGX as a strong player in the market.